Rezende-Neto Joao B, Rizoli Sandro B, Andrade Marcus V, Ribeiro Daniel D, Lisboa Thiago A, Camargos Elizabeth R, Martins Paula, Cunha-Melo Jose R
Department of Surgery, Universidade Federal de Minas Gerais,
J Trauma. 2010 Jan;68(1):42-50; discussion 50-1. doi: 10.1097/TA.0b013e3181c66393.
Experimental studies of uncontrolled hemorrhage demonstrated that permissive hypotension (PH) reduces blood loss, but its effect on clot formation remains unexplored. Desmopressin (DDAVP) enhances platelet adhesion promoting stronger clots. We hypothesized PH and DDAVP have additive effects and reduce bleeding in uncontrolled hemorrhage.
Rabbits (n = 42) randomized as follows: sham; normal blood pressure (NBP) resuscitation; PH resuscitation-60% baseline mean arterial pressure; NBP plus DDAVP 1 hour before (DDAVP NBP) or 15 minutes after beginning of shock (DDAVP T1 NBP); and PH plus DDAVP 1 hour before (DDAVP PH) or 15 minutes after beginning of shock (DDAVP T1 PH). Fluid resuscitation started 15 minutes after aortic injury and ended at 85 minutes. Intraabdominal blood loss was calculated, aortic clot sent for electron microscopy. Activated partial thromboplastin time, platelet count, thromboelastometry, arterial blood gases, and complete blood count were performed at baseline and 85 minutes. Analysis of variance was used for comparison.
NBP received more fluid volume and had greater intraabdominal blood loss. DDAVP, when administered preshock, significantly reduced blood loss in NBP and fluid requirement when given postshock. Platelets, arterial blood gas, complete blood count, and activated partial thromboplastin time were similar at 85 minutes. NBP delayed clot formation and worsened thrombodynamic potential on thromboelastometry, whereas PH and DDAVP improved. Electron microscopy showed lack of fibrin on NBP clots, whereas DDAVP and PH clots displayed exuberant fibrin/platelet aggregates. DDAVP NBP presented intermediate clots.
PH reduced bleeding and improved hemostasis compared with normotensive resuscitation. DDAVP given preshock exerted similar effects with normotensive resuscitation.
对失血性休克的实验研究表明,允许性低血压(PH)可减少失血量,但其对血栓形成的影响尚不清楚。去氨加压素(DDAVP)可增强血小板黏附,促进形成更强的血栓。我们假设PH和DDAVP具有相加作用,可减少失血性休克中的出血。
将42只兔子随机分组如下:假手术组;正常血压(NBP)复苏组;PH复苏组(平均动脉压为基线值的60%);NBP + DDAVP(休克前1小时给药,即DDAVP NBP)或休克开始后15分钟给药(即DDAVP T1 NBP);PH + DDAVP(休克前1小时给药,即DDAVP PH)或休克开始后15分钟给药(即DDAVP T1 PH)。主动脉损伤15分钟后开始液体复苏,并在85分钟时结束。计算腹腔内失血量,取主动脉血栓进行电子显微镜检查。在基线和85分钟时检测活化部分凝血活酶时间、血小板计数、血栓弹力图、动脉血气和全血细胞计数。采用方差分析进行比较。
NBP组接受的液体量更多,腹腔内失血量更大。休克前给予DDAVP可显著减少NBP组的失血量,休克后给药可减少液体需求量。85分钟时,血小板、动脉血气、全血细胞计数和活化部分凝血活酶时间相似。NBP组血栓形成延迟,血栓弹力图显示血栓动力学潜能恶化,而PH组和DDAVP组情况改善。电子显微镜检查显示,NBP组血栓缺乏纤维蛋白,而DDAVP组和PH组血栓显示有丰富的纤维蛋白/血小板聚集体。DDAVP NBP组血栓情况介于两者之间。
与正常血压复苏相比,PH可减少出血并改善止血效果。休克前给予DDAVP与正常血压复苏效果相似。